Elevance Health Inc
General ticker "ELV" information:
- Sector: Health Care
- Industry: Health Care Providers & Services
- Capitalization: $90.7B
Elevance Health Inc does not follow the US Stock Market performance with the rate: -12.7%.
Estimated limits based on current volatility of 1.1%: low 363.76$, high 371.72$
Factors to consider:
- Company included in S&P500 list
- Company pays dividends: last record date 2024-12-05, amount 1.63$ (Y1.76%)
- Current price 18.8% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [456.67$, 638.10$]
- 2024-12-30 to 2025-12-30 estimated range: [525.87$, 724.95$]
Financial Metrics affecting the ELV estimates:
- Positive: Non-GAAP EPS, $ of 33.11 > 2.29
- Positive: Operating profit margin, % of 78.18 > 19.51
- Positive: 7.18 < Operating cash flow per share per price, % of 7.20
- Positive: Inventory ratio change, % of -6.97 <= -1.03
- Negative: Interest expense per share, $ of 4.37 > 0.74
- Negative: Investing cash flow per share, $ of -23.62 <= -3.48
Short-term ELV quotes
Long-term ELV plot with estimates
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $138,639.00MM | $156,595.00MM | $171,340.00MM |
Operating Expenses | $129,693.00MM | $148,144.00MM | $37,380.00MM |
Operating Income | $8,946.00MM | $8,451.00MM | $133,960.00MM |
Non-Operating Income | $-1,021.00MM | $-682.00MM | $-126,245.00MM |
Interest Expense | $798.00MM | $851.00MM | $1,030.00MM |
Income(Loss) | $7,925.00MM | $7,769.00MM | $7,715.00MM |
Taxes | $1,830.00MM | $1,750.00MM | $1,728.00MM |
Profit(Loss) | $6,095.00MM | $6,019.00MM | $5,987.00MM |
Stockholders Equity | $36,060.00MM | $36,243.00MM | $39,306.00MM |
Inventory | $38,483.00MM | $11,381.00MM | $0.00MM |
Assets | $97,460.00MM | $102,755.00MM | $108,928.00MM |
Operating Cash Flow | $8,364.00MM | $8,399.00MM | $8,061.00MM |
Capital expenditure | $1,087.00MM | $1,152.00MM | $1,296.00MM |
Investing Cash Flow | $-9,638.00MM | $-4,560.00MM | $-5,572.00MM |
Financing Cash Flow | $423.00MM | $-1,318.00MM | $-3,349.00MM |
Earnings Per Share* | $25.04 | $24.56 | $25.69 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.